The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals

In overweight non-diabetic people rosiglitazone reduces oxidative stress and improves insulin sensitivity. Rosiglitazone also improves first and second phase insulin secretion and reduces markers of inflammation and GGT.